No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
LH Labcorp Holdings
- 199.650
- +3.280+1.67%
Close May 24 16:00 ET
- 200.430
- +0.780+0.39%
Post 18:40 ET
16.83BMarket Cap39.38P/E (TTM)
200.180High196.190Low724.59KVolume197.080Open196.370Pre Close144.19MTurnover0.86%Turnover Ratio41.86P/E (Static)84.29MShares232.46552wk High2.11P/B16.74BFloat Cap177.12452wk Low2.88Dividend TTM83.86MShs Float264.777Historical High1.44%Div YieldTTM2.03%Amplitude2.348Historical Low198.995Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Are Labcorp Holdings Inc.'s (NYSE:LH) Mixed Financials Driving The Negative Sentiment?
With its stock down 7.6% over the past three months, it is easy to disregard Labcorp Holdings (NYSE:LH). It seems that the market might have completely ignored the positive aspects of the company's
Why Labcorp (LH) Is a Top Value Stock for the Long-Term
Headquartered in Burlington, NC, Laboratory Corporation of America Holdings or Labcorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support.
Labcorp Holdings (NYSE:LH) Is Due To Pay A Dividend Of $0.72
Express News | Laboratory Corporation of America Holdings Files for Debt Shelf; Size Not Disclosed- SEC Filing
Express News | NYSE Order Imbalance 73104.0 Shares on Buy Side
Insider Sale: EVP, Chief Legal Officer Van Der Vaart Sandra D Sells Shares of Laboratory Corp ...
Comments
The company's stock seems overpriced compared to its peers, suggesting limited potential for further growth. Its low beta indicates it may not align with industry levels soon.
Insider selling shares below current price suggests contentment with lower valuation. Lack of insider buying and low insider ownership make the company a cautious investment choice.
Investors' optimism about Laboratory Corporation's performance could lead to inflated stock prices. The high share price puts existing and new shareholders at potential risk, possibly paying an unnecessary premium.
Labcorp's acquisition set to fortify its Massachusetts presence and push its goal of broadening cost-effective lab testing. The partnership with Baystate Health aims at promoting efficient, advanced healthcare services and improving patient and provider experience.
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
